Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1999
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999US5985278 Anti-αV-integrin monoclonal antibody
11/16/1999US5985277 Useful for diagnosis and treatement of corynebacterium infections and diseases.
11/16/1999US5985276 Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies
11/16/1999US5985272 Human myeloperoxidase and its therapeutic application
11/16/1999US5985267 Protein toxins active against lepidopteran pests
11/16/1999US5985262 Method of treatment with epithelium derived T-cell factor
11/16/1999CA2217668C Genetic markers for breast and ovarian cancer
11/16/1999CA2088600C Herpes simplex virus vp16 vaccines
11/16/1999CA2072007C Cloning vector for use in lactic acid bacteria and a method for constructing the same
11/16/1999CA2037900C Pokeweed antiviral protein - monoclonal antibody conjugates
11/16/1999CA2012149C Method for producing the hincii restriction endonuclease and methylase
11/16/1999CA2008698C Male flower specific gene sequences
11/16/1999CA2003360C Human vascular permeability factor
11/16/1999CA1340823C Insulin precursors, process for their preparation and process for the preparation of human insulin
11/13/1999CA2248987A1 Novel compounds
11/12/1999CA2270425A1 Amino acid sequence
11/11/1999WO1999057565A2 Methods for diagnosing and evaluating cancer
11/11/1999WO1999057564A1 Method for immobilising and/or crystallising biological macromolecules on carbon nanotubes and uses
11/11/1999WO1999057536A2 Cyclin activation kinase (cak) from human pathogens, and uses related thereto
11/11/1999WO1999057325A2 Enzymes mixture
11/11/1999WO1999057323A1 Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
11/11/1999WO1999057321A1 Method of determining the nucleotide sequence of oligonucleotides and dna molecules
11/11/1999WO1999057320A1 Antisense modulation of cd40 expression
11/11/1999WO1999057319A1 Electronic detection of nucleic acids using monolayers
11/11/1999WO1999057314A1 Electrical integrated nucleic acid isolation, purification and detection
11/11/1999WO1999057313A1 Method and device for isolating nucleic acids
11/11/1999WO1999057312A1 New method for the selection of clones of an expression library involving rearraying
11/11/1999WO1999057311A2 Novel method for the identification of clones conferring a desired biological property from an expression library
11/11/1999WO1999057309A1 Method and probes for the detection of chromosome aberrations
11/11/1999WO1999057308A1 Method for identifying and representing interindividual differences of dna sequences
11/11/1999WO1999057307A1 Method for non-radioactive detection of membrane-bonded nucleic acids and test kit
11/11/1999WO1999057297A1 Viral production process
11/11/1999WO1999057296A1 Partially deleted adenoviral vectors
11/11/1999WO1999057295A1 Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
11/11/1999WO1999057294A1 Lens transcriptional control elements and methods of use thereof
11/11/1999WO1999057293A1 Human bmp-7 promoter and method for exploring bone-related substance by using the same
11/11/1999WO1999057292A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
11/11/1999WO1999057291A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery
11/11/1999WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/11/1999WO1999057288A1 Endothelin-converting-enzyme like protein
11/11/1999WO1999057287A2 Beta-glucosidase coding sequences and protein from orpinomyces pc-2
11/11/1999WO1999057286A1 Putative lactamase proteins from mouse and human
11/11/1999WO1999057285A2 Sucrose phosphate synthase
11/11/1999WO1999057284A2 Attenuated influenza viruses
11/11/1999WO1999057283A1 Preparation of human papillomavirus e1 having helicase activity and method therefor
11/11/1999WO1999057282A2 Pesticidal toxins and nucleotide sequences which encode these toxins
11/11/1999WO1999057281A2 Peptide antibiotics which inhibit the growth of pneumococci, abc transporter and two-component signal transduction system proteins from streptococcus pneumoniae, and methods using the same
11/11/1999WO1999057280A2 Neisseria meningitidis antigens and compositions
11/11/1999WO1999057279A1 Plasmid for gene expression in pichia ciferrii and transformation method using the same
11/11/1999WO1999057278A2 IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI)
11/11/1999WO1999057277A2 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
11/11/1999WO1999057276A1 Multifunctional adhesin proteins and their display in microbial cells
11/11/1999WO1999057275A1 Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate
11/11/1999WO1999057274A1 Human protease associated proteins
11/11/1999WO1999057273A2 Cytoplasmic antiproteinase-3 coding sequence in gene therapy
11/11/1999WO1999057272A1 Peptide inhibitors of hiv replication
11/11/1999WO1999057271A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
11/11/1999WO1999057270A2 Human receptor molecules
11/11/1999WO1999057269A1 Human hrpi
11/11/1999WO1999057268A1 Chimeric receptors
11/11/1999WO1999057267A2 Human epididymal glytathione peroxidase
11/11/1999WO1999057266A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999WO1999057265A1 Chimeric decoy rnas having synergistic anti-hiv activity
11/11/1999WO1999057264A1 Method for prolonged storage of dna molecules and packaging implementing said method
11/11/1999WO1999057263A1 Modifying the expression of the fsh beta gene by homologous recombination
11/11/1999WO1999057261A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same
11/11/1999WO1999057255A1 Novel rhamnogalacturonan hydrolases
11/11/1999WO1999057253A2 Crystallizable jnk complexes
11/11/1999WO1999057249A1 Nicotianamine synthase and gene encoding the same
11/11/1999WO1999057247A1 Nucleic acids that control seed and fruit development in plants
11/11/1999WO1999057245A1 Methods of screening for agonists and antagonists of the interaction between the human kiaa0001 receptor and ligands thereof
11/11/1999WO1999057244A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
11/11/1999WO1999057241A2 Myelin basic protein peptides and uses thereof
11/11/1999WO1999057157A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein
11/11/1999WO1999057155A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein
11/11/1999WO1999057153A1 Heparanase specific molecular probes and their use in research and medical applications
11/11/1999WO1999057151A2 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY
11/11/1999WO1999057150A2 Multivalent antibody constructs
11/11/1999WO1999057149A2 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999WO1999057148A1 Melanocortin 1 receptor selective compounds
11/11/1999WO1999057147A1 Human thrombopoietin mutants
11/11/1999WO1999057145A2 Human bmp-4 promoter and method for exploring bone-related substance by using the same
11/11/1999WO1999057144A2 Human transcriptional regulator molecules
11/11/1999WO1999057143A1 Transcriptional regulatory factor
11/11/1999WO1999057140A2 Growth-associated protease inhibitor heavy chain precursor
11/11/1999WO1999057138A1 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppresssant and methods of use thereof
11/11/1999WO1999057133A2 Inhibitors of nf-kb activation
11/11/1999WO1999057132A1 Secreted proteins and polynucleotides encoding them
11/11/1999WO1999057131A1 Method of treating bladder and lower urinary tract syndromes
11/11/1999WO1999057129A1 Pathogeniv tau mutations
11/11/1999WO1999057128A1 Optimization of pest resistance genes using dna shuffling
11/11/1999WO1999056865A1 Device and method for producing a system of chain molecules on a support material
11/11/1999WO1999056784A2 Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10
11/11/1999WO1999056778A1 The cytokine family member, 2-19
11/11/1999WO1999056775A1 Use of interleukin-18 as vaccine adjuvant
11/11/1999WO1999056774A1 Viral chimeras comprised of caev and hiv-1 genetic elements
11/11/1999WO1999056771A2 Methods of raising animals for meat production
11/11/1999WO1999056769A2 Inhibition of helicobacter pylori proliferation
11/11/1999WO1999056759A1 Bone marrow cells as a source of neurons for brain and spinal cord repair